Occupational exposure to HIV in health care settings

被引:85
作者
Gerberding, JL [1 ]
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
关键词
D O I
10.1056/NEJMcp020892
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
While obtaining a peripheral venous blood sample from a patient with the acquired immunodeficiency syndrome (AIDS), a 35-year-old phlebotomist is injured by a bloody 18-gauge needle attached to a syringe. The patient has been taking didanosine and stavudine for more than six months, but her quantitative plasma human immunodeficiency virus (HIV) RNA titer and CD4 T-lymphocyte count have not been measured for many weeks. What is the appropriate postexposure treatment for the phlebotomist?.
引用
收藏
页码:826 / 833
页数:8
相关论文
共 37 条
  • [1] [Anonymous], 2000, GAO0160R
  • [2] [Anonymous], DHHS PUBL
  • [3] BELTRAMI EM, 2000, 4 DEC INT C NOS HEAL, P125
  • [4] BELTRAMI EM, 2000, 4 DEC INT C NOS HEAL, P128
  • [5] Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005
    Bottiger, D
    Johansson, NG
    Samuelsson, B
    Zhang, H
    Putkonen, P
    Vrang, L
    Oberg, B
    [J]. AIDS, 1997, 11 (02) : 157 - 162
  • [6] TIME-COURSE OF DETECTION OF VIRAL AND SEROLOGIC MARKERS PRECEDING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION - IMPLICATIONS FOR SCREENING OF BLOOD AND TISSUE DONORS
    BUSCH, MP
    LEE, LLL
    SATTEN, GA
    HENRARD, DR
    FARZADEGAN, H
    NELSON, KE
    READ, S
    DODD, RY
    PETERSEN, LR
    [J]. TRANSFUSION, 1995, 35 (02) : 91 - 97
  • [7] A case-control study of HIV seroconversion in health care workers after percutaneous exposure
    Cardo, DM
    Culver, DH
    Ciesielski, CA
    Srivastava, PU
    Marcus, R
    Abiteboul, D
    Heptonstall, J
    Ippolito, G
    Lot, F
    McKibben, P
    Bell, DM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (21) : 1485 - 1490
  • [8] CDC, 2001, Morbidity and Mortality Weekly Report, V50, P1
  • [9] REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT
    CONNOR, EM
    SPERLING, RS
    GELBER, R
    KISELEV, P
    SCOTT, G
    OSULLIVAN, MJ
    VANDYKE, R
    BEY, M
    SHEARER, W
    JACOBSON, RL
    JIMENEZ, E
    ONEILL, E
    BAZIN, B
    DELFRAISSY, JF
    CULNANE, M
    COOMBS, R
    ELKINS, M
    MOYE, J
    STRATTON, P
    BALSLEY, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) : 1173 - 1180
  • [10] Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVMET 012 randomised trial
    Guay, LA
    Musoke, P
    Fleming, T
    Bagenda, D
    Allen, M
    Nakabiito, C
    Sherman, J
    Bakaki, P
    Ducar, C
    Deseyve, M
    Emel, L
    Mirochnick, M
    Fowler, MG
    Mofenson, L
    Miotti, P
    Dransfield, K
    Bray, D
    Mmiro, F
    Jackson, JB
    [J]. LANCET, 1999, 354 (9181) : 795 - 802